The combination of aloin and metformin was found to inhibit the growth and invasion of liver cancer through the PI3K/AKT/mTOR pathway and induce apoptosis and autophagy, thereby exerting anti-tumor effects (Sun et al., 2020). Here, MTOR is linked to liver cancer.